Chemical Compound

pentazocine

CAS Registry Number 359-83-1
pentazocine chemical structure
Primary Record

pentazocine

In stock
6,704 g
Purity
98.8 %
CAS
359-83-1

Compound Identifiers & Properties

CAS
359-83-1
PubChem CID
441278
SMILES
C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
Canonical SMILES
CC(C)=CCN1CC[C@@]2(C)c3cc(O)ccc3C[C@@H]1[C@@H]2C

Names & Synonyms

  • pentazocine
  • Pentazocin
  • L-pentazocine
  • Fortalgesic
  • Fortalin
  • Pentazocinum
  • Pentagin
  • Fortral
  • Liticon
  • Sosigon
  • Levopentazocine
  • Pentazocina
  • Talwin
  • Pentazocaine
  • Sosegon
  • Pentazocine, L-
  • Soseton
  • Talacen
  • Talwan
  • Pentazocine civ
  • dl-Pentazocine
  • Pentazocine, (-)-
  • Lexir
  • cis-(-)-Pentazocine
  • Pentazocina [DCIT]
  • (-)-PENTAZOCINE
  • Fortral (TN)
  • (-)-cis-Pentazocine
  • (+)-Pentazocine
  • (-)-alpha-Pentazocine
  • Fortwin (TN)
  • Talacen (TN)
  • (+-)-Pentazocine
  • Fortal (TN)
  • Lactate, Pentazocine
  • Talwin (TN)
  • Pentazocinum [INN-Latin]
  • Talwin NX (TN)
  • Talwin PX (TN)
  • (+/-)-pentazocine
  • Algopent (free base)
  • Pentazocine,(+/-)
  • UNII-768DQ5A5AI
  • II-C-2
  • Pentazocine 2R,6R,11R-form
  • cis-(+-)-Pentazocine
  • CHEMBL560
  • PENTAZOCINE [MI]
  • PENTAZOCINE (+)
  • PENTAZOCINE (-)
  • RefChem:928798
  • 768DQ5A5AI
  • cis-(+/-)-Pentazocine
  • PENTAZOCINE [INN]
  • PENTAZOCINE [JAN]
  • RP4A60D26L
  • UNII-RP4A60D26L
  • 2-(3,3-Dimethylallyl)cyclazocine
  • PENTAZOCINE [HSDB]
  • PENTAZOCINE [USAN]
  • D0W6DG
  • NIH 7958
  • PENTAZOCINE [VANDF]
  • SCHEMBL2492
  • CHEBI:7982
  • PENTAZOCINE [MART.]
  • Pentazocine 2R,6R,11R-form [MI]
  • WIN 20228
  • PENTAZOCINE [WHO-DD]
  • ZINC596
  • HSDB 3150
  • WIN-20228
  • 359-83-1
  • C19H27NO
  • GTPL1606
  • 359-83-1 (free base)
  • DEA No. 9709
  • Pentazocine (JP15/USP/INN)
  • Pentazocine (JP18/USP/INN)
  • DTXSID7023433
  • NIH-7958
  • NSC-107430
  • Pentazocine [USAN:INN:BAN:JAN]
  • WIN 20,228
  • EINECS 206-634-6
  • KF-1820
  • N02AD01
  • PENTAZOCINE [EP IMPURITY]
  • PENTAZOCINE CIV [USP-RS]
  • VOKSWYLNZZRQPF-GDIGMMSISA-N
  • (-)-.ALPHA.-PENTAZOCINE
  • PENTAZOCINE [EP MONOGRAPH]
  • NSC 107430
  • Pentazocine (1mg/ml in Methaniol)
  • PENTAZOCINE [USP MONOGRAPH]
  • C19-H27-N-O
  • Pentazocine [USAN:BAN:INN:JAN]
  • EINECS 244-593-6
  • Pentazocine [USAN:USP:INN:BAN:JAN]
  • BDBM50001028
  • CID441278
  • 7488-49-5
  • DB00652
  • FP26817
  • FP26819
  • 2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan
  • J419.448I
  • NS00010467
  • 2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan
  • C07421
  • D00498
  • Pentazocine, Pentazocin, Sosegon, WIN 20228
  • 2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan
  • Q415793
  • (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol
  • 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol
  • 3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol
  • 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-
  • 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-
  • (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol
  • (2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol
  • (2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-2,6-methano-3-benzazocin-8-ol
  • (2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol
  • (2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol
  • 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-rel-
  • 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2alpha,6alpha,11R*)-
  • (-)-cis-Pentazocine; 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-; 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2R,6R,11R)- (9CI); 2,6-Methano-3-benzazocin-8-ol, 1,2
  • (11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2alpha,6alpha-methano-3-benzazocine-8-ol
  • (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo(7.3.1.0^(2,7))trideca-2,4,6-trien-4-ol
  • (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo(7.3.1.02,7)trideca-2,4,6-trien-4-ol
  • (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0?,?]trideca-2(7),3,5-trien-4-ol
  • (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0^{2,7}]trideca-2,4,6-trien-4-ol
  • (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol
  • (2R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2alpha,6alpha-methano-3-benzazocine-8-ol
  • (2R,11R)-6,11-Dimethyl-1,2,3,4,5,6-hexahydro-3-(3-methyl-2-butenyl)-2alpha,6alpha-methano-3-benzoazocine-8-ol
  • (2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
  • (2R,6R,11R)-rel-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-2,6-methano-3-benzazocin-8-ol
  • (6R,11S)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
  • [2R,6R,11R,(-)]-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocine-8-ol
  • 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol
  • 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11- dimethyl-3-(3-methyl-2-butenyl)-, (2?,6?,11R*)-
  • 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R)-
  • 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2.alpha.,6.alpha.,11R*)-
  • 2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(3-METHYL-2-BUTENYL)-, (2R,6R,11R)-
  • 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, [2R-(2.alpha.,6.alpha.,11R*)]-
  • 2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(3-METHYL-2-BUTENYL)-, CIS-(-)-
  • 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-4-(3-methyl-2-butenyl)-
  • 206-634-6
  • 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
  • 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Pentazocine)
  • rel-(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol